The Role of Extracellular Spacer Regions in the Optimal Design of Chimeric Immune Receptors
Top Cited Papers
- 1 May 2005
- journal article
- Published by Wolters Kluwer Health in Journal of Immunotherapy
- Vol. 28 (3) , 203-211
- https://doi.org/10.1097/01.cji.0000161397.96582.59
Abstract
Human peripheral blood lymphocytes can be transduced to express antigen-dependent CD3zeta chimeric immune receptors (CIRs), which function independently of the T-cell receptor (TCR). Although the exact function of these domains is unclear, previous studies imply that an extracellular spacer region is required for optimal CIR activity. In this study, four scFvs (in the context of CIRs with or without extracellular spacer regions) were used to target the human tumor-associated antigens carcinoembryonic antigen (CEA), neural cell adhesion molecule (NCAM), the oncofetal antigen 5T4, and the B-cell antigen CD19. In all cases human T-cell populations expressing the CIRs were functionally active against their respective targets, but the anti-5T4 and anti-NCAM CIRs showed enhanced specific cytokine release and cytotoxicity only when possessing an extracellular spacer region. In contrast, the anti-CEA and anti-CD19 CIRs displayed optimal cytokine release activity only in the absence of an extracellular spacer. Interestingly, mapping of the scFv epitopes has revealed that the anti-CEA scFv binds close to the amino-terminal of CEA, which is easily accessible to the CIR. In contrast, CIRs enhanced by a spacer domain appear to bind to epitopes residing closer to the cell membrane, suggesting that a more flexible extracellular domain may be required to permit the efficient binding of such epitopes. These results show that a spacer is not necessary for optimal activity of CIRs but that the optimal design varies.Keywords
This publication has 33 references indexed in Scilit:
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Serial Triggering of T Cell Receptors Results in Incremental Accumulation of Signaling IntermediatesJournal of Biological Chemistry, 2002
- Primary Polyclonal Human T Lymphocytes Targeted to Carcino-Embryonic Antigens and Neural Cell Adhesion Molecule Tumor Antigens by CD3ζ-Based Chimeric Immune ReceptorsJournal of Immunotherapy, 2002
- Weak TCR stimulation induces a calcium signal that triggers IL-4 synthesis, stronger TCR stimulation induces MAP kinases that control IFN-γ productionEuropean Journal of Immunology, 2001
- Functional balance between T cell chimeric receptor density and tumor associated antigen density: CTL mediated cytolysis and lymphokine productionGene Therapy, 2000
- Impact of chimeric immune receptor extracellular protein domains on T cell functionGene Therapy, 1999
- Anti-Tumor Activity of Human T Cells Expressing the CC49-zeta Chimeric Immune ReceptorHuman Gene Therapy, 1999
- Apoptosis Induced in T Cells by Human Neuroblastoma Cells: Role of Fas LigandNatural Immunity, 1998
- Antigen‐specific targeting of CD28‐mediated T cell co‐stimulation using chimeric single‐chain antibody variable fragment‐CD28 receptorsEuropean Journal of Immunology, 1996
- Phage libraries for generation of clinically useful antibodiesThe Lancet, 1994